Are you prepared to seize opportunities and avoid risks in a heavily regulated space?
CANNABIS LICENSE APPLICATIONS
Cultivation? Dispensary? Micro-License? What license types are available in your state and which is best suited for your business vision?
Do you have the right line-up of professional consultants with first-hand experience in the cannabis licensing trenches?
The cannabis market is fiercely competitive, heavily regulated, and is particularly expensive to get in. License application preparation requires extensive investments of energy, effort, and funds— with no guarantee of success, even for applicants with experience in cultivation, retail dispensaries, and distribution. We understand how daunting and overwhelming this process may seem, especially for first time applicants. You are not alone. Like many clients we have served, you need a guide to provide a roadmap to success and ongoing support from preliminary assessment to final submission.
Take your best shot by partnering with the trusted professionals at ‘68PARTNERS who have decades of real-world experience navigating complex regulations, writing compelling narratives, engaging a network of strategic partners— and the know-how to get it done right.
& FDA COMPLIANCE
What is your commercialization strategy to get your FDA regulated products on the market—
and keep them there?
Does your packaging, labeling, and website content balance FDA compliance with creativity?
The FDA requires you to comply, but does not tell you how. Lawyers charge to tell you what the regulations are, but not how to apply them creatively to get your products on the market. Branding experts tell you “just don't make medical claims”, but do not know how to navigate regulations to get your product compliantly on the market. With all the mixed messaging out there, you need straight-talk from experienced professionals with the know how to navigate local, state, and federal regulations, and translate them into a practical regulatory strategy that serves your unique brand.
With decades of real-world experience commercializing FDA regulated products, '68PARTNERS knows how to avoid regulatory black ice™, and guide you on a path to sustainable brand equity. From start-ups to mid-size to multi-national corporations, we design practical commercialization and compliance solutions for any size organization, at any stage of the product life cycle.
VIRTUAL CHIEF STRATEGY
& COMPLIANCE OFFICER
Do you have the right organizational structure and leadership team to persuade investors and
license application reviewers?
Can you afford to hire all the people needed to execute a business plan or deliver on the promises you made in your license application?
Whether you are a brand solopreneur, own a 100,000 square foot cultivation facility, operate a retail store-front or dispensary, or are a new license applicant, a thoughtful business strategy that prioritizes compliance will set you apart. The Virtual Chief Strategy & Compliance Officer (CSCO) does both. This uniquely cost-effective executive role combines FDA compliance oversight and business strategy functions that are essential to building sustainable brand equity and successful cannabis businesses.
Available on a full-time, part-time or advisory basis, the CSCO will leverage decades of experience in the pharmaceutical industry, law, and FDA compliance consulting.
MEET '68 PARTNERS
"Compliance is the segue to sustainable brand equity.™ " -- Sheri Tarr
Founder & Chief Advisor
Sheri Tarr, JD
Uniquely positioned at the intersection of cannabis, commercialization, and regulatory compliance, SHERI TARR, JD is the Founder and Chief Advisor of ‘68PARTNERS, a woman-owned and operated business. A former pharmaceutical industry sales and marketing executive responsible for launching products worldwide, Sheri has amassed over three decades of real-world experience operating in an FDA-regulated environment. After her pharmaceutical career, Sheri flipped the script and became an attorney who spent her career in the courtroom holding pharmaceutical companies accountable for deceptive marketing and defective manufacturing. More inspired by medical innovation than litigation, Sheri founded ‘68PARTNERS, a strategic consultancy dedicated to helping cannabis brands and license applicants build sustainable businesses that have a transformative impact on consumers, patients, and the economy.
A former pharmaceutical executive and mass tort litigator, Sheri has a deep understanding of the complex business, organizational, and regulatory challenges faced by life sciences and cannabis industry stakeholders. She knows first-hand the tension between profit and risk, and has witnessed the adverse consequences to companies and consumers that result when these priorities are misaligned. Using her business savvy, legal prowess, and regulatory know-how, Sheri collaborates with clients of ‘68PARTNERS to develop practical commercialization and compliance strategies that strike a healthy balance between financial goals and foreseeable risk.